From: Drug eluting balloons for de novocoronary lesions – a systematic review and meta-analysis
Study | Paclitaxel eluting balloon | Controls stent type(s) | Setting | Clopidogrel (mts) | Follow-up (mts) | Primary endpoint | MACE | TLR | Bare metal stenting |
---|---|---|---|---|---|---|---|---|---|
DEB-AMI | DIOR 2nd generation | TAXUS DES, Genius Magic Euroscore BMS | STEMI | 12 | 6 | LLL | death, MI, TVR | restenosis >50% ischemia | 100% |
Stella et al. | DIOR 1st generation | TAXUS DES, Liberté BMS | stable/unstable CAD, bifurcation | 3 after BMS, 12 after DES | 12 (angio 6) | LLL | death, MI, TVR | restenosis >50% ischemia | 100% |
PEPCAD III | Coroflex DEBlue | Cypher DES | stable/unstable CAD | 1 after DEB | 9 | LLL | NA | NA | 100% |
PERFECT | SeQuent Please+ PERFECT Stent | PERFECT Stent (EPC capturing Stent) | Stable CAD | 3 | 6 | LLL | death, MI, TLR | NA | 100% |
BELLO | IN.PACT Falcon | TAXUS DES | stable/unstable CAD small vessels | 3 after DEB, 12 after DES | 6 | LLL | death, MI, TVR | any repeat revascularization | 20.2% |
Herdeg et al. | GENIE Acrostak | TAXUS DES, Multi-Link BMS | stable CAD | 6 | 6 | LLL | death, MI, TVR, stent thrombosis | any repeat revascularization | 100% |
Ali et al. | SeQuent Please | TAXUS DES | stable CAD in diabetics | NA | 9 | LLL | NA | NA | 100% |
PICCOLETTO | DIOR 1st generation | TAXUS DES | stable/unstable CAD small vessels | 1 after DEB, 3 after BMS, 12 after DES/unstable | 9 (angio 6) | diameter stenosis | death, STEMI, TLR | >50% restenosis | NA (>100%) |